149 related articles for article (PubMed ID: 15277398)
1. Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels.
Gu HF; Efendic S; Nordman S; Ostenson CG; Brismar K; Brookes AJ; Prince JA
Diabetes; 2004 Aug; 53(8):2137-42. PubMed ID: 15277398
[TBL] [Abstract][Full Text] [Related]
2. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
Nordman S; Ostenson CG; Efendic S; Gu HF
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):186-90. PubMed ID: 19053027
[TBL] [Abstract][Full Text] [Related]
3. High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people.
Florez JC; Wiltshire S; Agapakis CM; Burtt NP; de Bakker PI; Almgren P; Bengtsson Boström K; Tuomi T; Gaudet D; Daly MJ; Hirschhorn JN; McCarthy MI; Altshuler D; Groop L
Diabetes; 2006 Jan; 55(1):128-35. PubMed ID: 16380485
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study.
Karamohamed S; Demissie S; Volcjak J; Liu C; Heard-Costa N; Liu J; Shoemaker CM; Panhuysen CI; Meigs JB; Wilson P; Atwood LD; Cupples LA; Herbert A;
Diabetes; 2003 Jun; 52(6):1562-7. PubMed ID: 12765971
[TBL] [Abstract][Full Text] [Related]
5. Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility.
Groves CJ; Wiltshire S; Smedley D; Owen KR; Frayling TM; Walker M; Hitman GA; Levy JC; O'Rahilly S; Menzel S; Hattersley AT; McCarthy MI
Diabetes; 2003 May; 52(5):1300-5. PubMed ID: 12716770
[TBL] [Abstract][Full Text] [Related]
6. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
Blomqvist ME; Chalmers K; Andreasen N; Bogdanovic N; Wilcock GK; Cairns NJ; Feuk L; Brookes AJ; Love S; Blennow K; Kehoe PG; Prince JA
Neurobiol Aging; 2005 Jun; 26(6):795-802. PubMed ID: 15718037
[TBL] [Abstract][Full Text] [Related]
7. Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene.
Bartl J; Scholz CJ; Hinterberger M; Jungwirth S; Wichart I; Rainer MK; Kneitz S; Danielczyk W; Tragl KH; Fischer P; Riederer P; Grünblatt E
BMC Med Genet; 2011 Nov; 12():151. PubMed ID: 22107728
[TBL] [Abstract][Full Text] [Related]
8. Association of polymorphisms in the insulin-degrading enzyme gene with type 2 diabetes in the Korean population.
Kwak SH; Cho YM; Moon MK; Kim JH; Park BL; Cheong HS; Shin HD; Jang HC; Kim SY; Lee HK; Park KS
Diabetes Res Clin Pract; 2008 Feb; 79(2):284-90. PubMed ID: 17913278
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in a haplotype block spanning IDE influences Alzheimer disease.
Prince JA; Feuk L; Gu HF; Johansson B; Gatz M; Blennow K; Brookes AJ
Hum Mutat; 2003 Nov; 22(5):363-71. PubMed ID: 14517947
[TBL] [Abstract][Full Text] [Related]
10. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
[TBL] [Abstract][Full Text] [Related]
11. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.
Bertram L; Blacker D; Mullin K; Keeney D; Jones J; Basu S; Yhu S; McInnis MG; Go RC; Vekrellis K; Selkoe DJ; Saunders AJ; Tanzi RE
Science; 2000 Dec; 290(5500):2302-3. PubMed ID: 11125142
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes.
Rudovich N; Pivovarova O; Fisher E; Fischer-Rosinsky A; Spranger J; Möhlig M; Schulze MB; Boeing H; Pfeiffer AF
J Mol Med (Berl); 2009 Nov; 87(11):1145-51. PubMed ID: 19809796
[TBL] [Abstract][Full Text] [Related]
13. Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease.
Blomqvist ME; Silburn PA; Buchanan DD; Andreasen N; Blennow K; Pedersen NL; Brookes AJ; Mellick GD; Prince JA
Neurogenetics; 2004 Jun; 5(2):115-9. PubMed ID: 15088150
[TBL] [Abstract][Full Text] [Related]
14. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease.
Abraham R; Myers A; Wavrant-DeVrieze F; Hamshere ML; Thomas HV; Marshall H; Compton D; Spurlock G; Turic D; Hoogendoorn B; Kwon JM; Petersen RC; Tangalos E; Norton J; Morris JC; Bullock R; Liolitsa D; Lovestone S; Hardy J; Goate A; O'Donovan M; Williams J; Owen MJ; Jones L
Hum Genet; 2001 Dec; 109(6):646-52. PubMed ID: 11810277
[TBL] [Abstract][Full Text] [Related]
15. No association between the insulin degrading enzyme gene and Alzheimer's disease in a Japanese population.
Sakai A; Ujike H; Nakata K; Takehisa Y; Imamura T; Uchida N; Kanzaki A; Yamamoto M; Fujisawa Y; Okumura K; Kuroda S
Am J Med Genet B Neuropsychiatr Genet; 2004 Feb; 125B(1):87-91. PubMed ID: 14755451
[TBL] [Abstract][Full Text] [Related]
16. Mutation screening of a haplotype block around the insulin degrading enzyme gene and association with Alzheimer's disease.
Feuk L; McCarthy S; Andersson B; Prince JA; Brookes AJ
Am J Med Genet B Neuropsychiatr Genet; 2005 Jul; 136B(1):69-71. PubMed ID: 15858821
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease.
Ertekin-Taner N; Allen M; Fadale D; Scanlin L; Younkin L; Petersen RC; Graff-Radford N; Younkin SG
Hum Mutat; 2004 Apr; 23(4):334-42. PubMed ID: 15024728
[TBL] [Abstract][Full Text] [Related]
18. Insulin-degrading enzyme haplotypes affect insulin levels but not dementia risk.
Marlowe L; Peila R; Benke KS; Hardy J; White LR; Launer LJ; Myers A
Neurodegener Dis; 2006; 3(6):320-6. PubMed ID: 17192720
[TBL] [Abstract][Full Text] [Related]
19. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
20. A new variant in the human Kv1.3 gene is associated with low insulin sensitivity and impaired glucose tolerance.
Tschritter O; Machicao F; Stefan N; Schäfer S; Weigert C; Staiger H; Spieth C; Häring HU; Fritsche A
J Clin Endocrinol Metab; 2006 Feb; 91(2):654-8. PubMed ID: 16317062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
